Boundless Bio logo

Boundless Bio Funding & Investors

Los Angeles, CA

Boundless Bio, a San Diego based company backed by ARCH Venture Partners, is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.

boundlessbio.com

Total Amount Raised: $251,400,000

Boundless Bio Funding Rounds

  • IPO

    Unknown

  • Series C

    $100,000,000

    Series C Investors

    Leaps by Bayer
    RA Capital Management
    Redmile Group
    Sectoral Asset Management
    Vertex Ventures HC
    GT Healthcare Capital Partners
    Fidelity Investments
    Surveyor Capital
    Wellington Management
    Arch Venture Partners
    Piper Heartland Healthcare Capital
    Nextech Invest
    Partner Fund Management
    Alexandria Real Estate Equities
    City Hill Ventures
    Logos Capital

  • Series B

    $105,000,000

    Series B Investors

    Nextech Invest
    RA Capital Management
    Logos Capital
    Surveyor Capital
    Partner Fund Management
    Wellington Management
    Redmile Group
    Fidelity Investments
    Arch Venture Partners
    City Hill Ventures
    Alexandria Real Estate Equities
    GT Healthcare Capital Partners
    Boxer Capital
    Vertex Ventures HC

  • Series A

    $46,400,000

    Series A Investors

    Arch Venture Partners
    City Hill Ventures
    GT Healthcare Capital Partners
    Boxer Capital
    Alexandria Real Estate Equities
    Vertex Holdings
Funding info provided by Diffbot.